Pier-Luigi Lollini Selected Research

1,7- dimethyl- 1,4,7,10- tetraazacyclododecane

2/2014

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pier-Luigi Lollini Research Topics

Disease

68	Neoplasms (Cancer) 04/2022 - 03/2002
19	Carcinoma (Carcinomatosis) 11/2021 - 04/2003
17	Rhabdomyosarcoma 01/2022 - 07/2002
16	Carcinogenesis 04/2019 - 09/2002
15	Ewing Sarcoma (Sarcoma, Ewing) 04/2022 - 03/2002
12	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2007
11	Breast Neoplasms (Breast Cancer) 11/2019 - 06/2004
8	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 05/2005
7	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 05/2005
3	Hypoxia (Hypoxemia) 01/2021 - 01/2013
2	Hepatitis B 01/2018 - 10/2010
2	Communicable Diseases (Infectious Diseases) 06/2015 - 10/2010
1	Genetic Translocation (Chromosomal Translocation) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Disease Progression 09/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Papilloma (Papillomatosis) 01/2018
1	Noncommunicable Diseases 01/2018
1	Colonic Neoplasms (Colon Cancer) 11/2016
1	Colorectal Neoplasms (Colorectal Cancer) 11/2016

Drug/Important Bio-Agent (IBA)

32	VaccinesIBA 04/2019 - 10/2002
11	AntibodiesIBA 01/2021 - 11/2004
11	Interleukin-12 (IL 12)IBA 01/2018 - 06/2003
11	Proteins (Proteins, Gene)FDA Link 02/2011 - 07/2002
10	AntigensIBA 01/2013 - 02/2003
9	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 05/2003
7	Monoclonal AntibodiesIBA 01/2018 - 07/2002
7	CytokinesIBA 11/2016 - 04/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2006
5	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
5	Biological ProductsIBA 11/2019 - 11/2009
5	Insulin-Like PeptidesIBA 04/2019 - 02/2010
5	DNA VaccinesIBA 01/2014 - 03/2005
4	Oncogene Proteins (Oncogene Protein)IBA 08/2017 - 11/2004
4	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 06/2003
3	dactolisibIBA 01/2022 - 01/2010
3	EnzymesIBA 01/2021 - 12/2010
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 07/2002
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2007
3	ErbB Receptors (EGF Receptor)IBA 11/2016 - 07/2002
3	PerforinIBA 05/2015 - 04/2003
3	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 05/2005
3	Tamoxifen FDA LinkGeneric 12/2011 - 06/2003
3	Neoplasm Antigens (Tumor Antigens)IBA 12/2011 - 02/2003
3	Cancer VaccinesIBA 06/2011 - 11/2007
3	Myosins (Myosin)IBA 04/2009 - 06/2003
3	Peptides (Polypeptides)IBA 03/2006 - 05/2003
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2005 - 03/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2020
2	LigandsIBA 10/2020 - 08/2007
2	Sirolimus (Rapamycin)FDA Link 10/2020 - 01/2010
2	Phosphotransferases (Kinase)IBA 04/2019 - 05/2005
2	human ERBB2 proteinIBA 04/2019 - 01/2018
2	Neutralizing AntibodiesIBA 02/2019 - 03/2002
2	Caveolin 1IBA 01/2019 - 04/2006
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 01/2010
2	CarcinogensIBA 01/2018 - 02/2005
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 02/2014
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 06/2004
2	InterleukinsIBA 11/2007 - 06/2004
2	Connective Tissue Growth FactorIBA 01/2007 - 03/2004
2	Growth Factor ReceptorsIBA 10/2005 - 07/2002
2	Small Interfering RNA (siRNA)IBA 06/2005 - 03/2004
1	Lamin Type A (Lamin A)IBA 04/2022
1	ZyxinIBA 01/2022
1	MTOR InhibitorsIBA 01/2022
1	EWS-FLI fusion proteinIBA 01/2022
1	TrabectedinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Sunitinib (Sutent)FDA Link 11/2021
1	ClaudinsIBA 11/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	InterferonsIBA 10/2020
1	Mitogen-Activated Protein KinasesIBA 10/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	tyrosine receptor (receptor, tyrosine)IBA 04/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	quinolineIBA 01/2018
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	MC3343IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017
1	Protein Isoforms (Isoforms)IBA 08/2017
1	Trastuzumab (Herceptin)FDA Link 08/2017
1	Cetuximab (Erbitux)FDA Link 11/2016
1	1,7- dimethyl- 1,4,7,10- tetraazacyclododecaneIBA 02/2014
1	maltolIBA 02/2014
1	Mitochondrial DNA (mtDNA)IBA 03/2013

Therapy/Procedure

20	Therapeutics 01/2022 - 07/2002
9	Immunotherapy 10/2020 - 02/2003
3	Drug Therapy (Chemotherapy) 09/2020 - 01/2013
1	Aftercare (After-Treatment) 01/2021
1	Intravenous Injections 02/2019
1	Tertiary Prevention 06/2015